Bank Of America Corp Nex Immune, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.3 - $0.6 $102 - $204	341 Added 741.3%	387 $0
Q4 2022 Feb 10, 2023	BUY	$0.21 - $18.5 $9 - $832	45 Added 4500.0%	46 $0
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $627 - $18,305	-1,046 Reduced 99.9%	1 $0
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $10,482 - $30,471	-6,511 Reduced 86.15%	1,047 $1,000
Q1 2022 May 16, 2022	SELL	$1.79 - $4.65 $18,075 - $46,955	-10,098 Reduced 57.19%	7,558 $32,000
Q4 2021 Feb 08, 2022	BUY	$4.11 - $15.13 $59,903 - $220,519	14,575 Added 473.06%	17,656 $81,000
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $14,602 - $23,913	1,415 Added 84.93%	3,081 $47,000
Q2 2021 Sep 13, 2021	BUY	$14.98 - $23.89 $24,956 - $39,800	1,666 New	1,666 $27,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $2.42M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.